About James Payne
Form D filings for Theratome Bio in 2023 list James Payne as executive officer.
James Payne first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name James Payne in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Payne works with at each company, as listed on that company's latest Form D.
Theratome Bio, Inc. · Form D, Sep 21, 2023
MR
Michael Redman
Executive officer and director
KP
Keith March MD PhD
Executive officer and director
BM
Brad Miller
Director
MT
Michael Trotta
Director